Work

Linezolid (ZYVOX), the First Member of a Completely New Class of Antibacterial Agents for Treatment of Serious Gram-Positive Infections

Year: 2008

Type: review

Source: Journal of Medicinal Chemistry

DOI: 10.1021/jm800038g

Authors: Steven J. Brickner, Michael R. Barbachyn, Douglas K. Hutchinson, Peter R. Manninen

Institution: Eli Lilly (United States)

Language: English

Topic: Antibiotics Pharmacokinetics and Efficacy

Subfield: Pharmacology (medical)

Field: Medicine

Domain: Health Sciences

Open Access status: closed

Funder: Centers for Disease Control and Prevention

OpenAlex ID: W1994320720

FWCI: 1.111

Cites: 68

Cited by: 205

Related to: 10